• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 2 型糖尿病中,单核细胞来源的髓样抑制细胞增加与高血糖相关,是感染和肿瘤发生的危险因素。

Increased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence.

机构信息

Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.

School of Nursing, Anhui Medical University, Hefei, 230032, Anhui, China.

出版信息

Sci Rep. 2024 Feb 22;14(1):4384. doi: 10.1038/s41598-024-54496-w.

DOI:10.1038/s41598-024-54496-w
PMID:38388535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10883972/
Abstract

To investigate the frequency of monocytic myeloid-derived suppressor cells (M-MDSCs) in type 2 diabetes mellitus (T2DM) patients and explore the potential associations between M-MDSCs, glycemic control, and the occurrence of infections and tumor. 102 healthy and 77 T2DM individuals were enrolled. We assessed the M-MDSCs frequency, levels of fasting plasma glucose (FPG), haemoglobin A1c (HbA1c), and other relevant indicators. Each patient underwent a follow-up of at least 6 months after M-MDSCs detection. The M-MDSCs frequency was significantly higher in patients with poor glycemic control (PGC) compared to the healthy population (P < 0.001), whereas there was no significant difference between patients with good glycemic control and the healthy (P > 0.05). There was a positive correlation between the M-MDSCs frequency and FPG, HbA1c (R = 0.517 and 0.315, P < 0.001, respectively). T2DM patients with abnormally increased M-MDSCs have a higher incidence of infection and tumor (48.57% and 11.43% respectively). Our results shed new light on the pathogenesis of T2DM, help to understand why T2DM patients are susceptible to infection and tumor and providing novel insights for future prevention and treatment of T2DM.

摘要

目的

探讨 2 型糖尿病(T2DM)患者中单核细胞来源的髓系抑制细胞(M-MDSC)的频率,并探讨 M-MDSC 与血糖控制、感染和肿瘤发生之间的潜在关联。方法:纳入 102 名健康个体和 77 名 T2DM 个体。评估 M-MDSC 频率、空腹血糖(FPG)、糖化血红蛋白(HbA1c)水平和其他相关指标。每位患者在检测 M-MDSC 后至少进行了 6 个月的随访。结果:与健康人群相比,血糖控制不佳(PGC)患者的 M-MDSC 频率显著升高(P<0.001),而血糖控制良好患者与健康人群之间无显著差异(P>0.05)。M-MDSC 频率与 FPG、HbA1c 呈正相关(R=0.517 和 0.315,P<0.001)。M-MDSC 异常升高的 T2DM 患者感染和肿瘤的发生率较高(分别为 48.57%和 11.43%)。结论:本研究结果为 T2DM 的发病机制提供了新的视角,有助于理解为什么 T2DM 患者易感染和发生肿瘤,并为 T2DM 的未来预防和治疗提供了新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/0e6f5254413e/41598_2024_54496_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/083df3b90c32/41598_2024_54496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/c1fff5e1054f/41598_2024_54496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/1a8f7da4b6a8/41598_2024_54496_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/fc210c27b730/41598_2024_54496_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/0e6f5254413e/41598_2024_54496_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/083df3b90c32/41598_2024_54496_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/c1fff5e1054f/41598_2024_54496_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/1a8f7da4b6a8/41598_2024_54496_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/fc210c27b730/41598_2024_54496_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60cc/10883972/0e6f5254413e/41598_2024_54496_Fig5_HTML.jpg

相似文献

1
Increased monocytic myeloid-derived suppressor cells in type 2 diabetes correlate with hyperglycemic and was a risk factor of infection and tumor occurrence.在 2 型糖尿病中,单核细胞来源的髓样抑制细胞增加与高血糖相关,是感染和肿瘤发生的危险因素。
Sci Rep. 2024 Feb 22;14(1):4384. doi: 10.1038/s41598-024-54496-w.
2
Correlation between long-term glycemic variability and cognitive function in middle-aged and elderly patients with type 2 diabetes mellitus: a retrospective study.2 型糖尿病中老年患者长期血糖变异性与认知功能的相关性:一项回顾性研究。
PeerJ. 2023 Dec 20;11:e16698. doi: 10.7717/peerj.16698. eCollection 2023.
3
Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study.循环单核细胞来源的髓系抑制细胞的持续积累导致肾移植受者细菌感染后的免疫抑制:一项初步研究。
Transpl Immunol. 2018 Jun;48:10-17. doi: 10.1016/j.trim.2018.02.007. Epub 2018 Feb 22.
4
Myeloid-derived suppressor cells suppress CD4+ T cell activity and prevent the development of type 2 diabetes.髓源性抑制细胞抑制 CD4+T 细胞的活性,防止 2 型糖尿病的发生。
Acta Biochim Biophys Sin (Shanghai). 2018 Apr 1;50(4):362-369. doi: 10.1093/abbs/gmy014.
5
Comparative study on hemoglobin A1c, glycated albumin and glycosylated serum protein in aplastic anemia patients with Type 2 diabetes mellitus.再生障碍性贫血合并 2 型糖尿病患者糖化血红蛋白、糖化白蛋白和糖基化血清蛋白的对比研究。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20192300.
6
Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.空腹血糖受损个体中使用空腹血糖和糖化血红蛋白水平预测2型糖尿病:泰国的一项横断面研究
BMJ Open. 2020 Nov 10;10(11):e041269. doi: 10.1136/bmjopen-2020-041269.
7
Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation.单核细胞来源的髓系抑制细胞中的基质金属蛋白酶-9 与异基因造血干细胞移植中的早期感染和临床结局相关。
Biol Blood Marrow Transplant. 2018 Jan;24(1):32-42. doi: 10.1016/j.bbmt.2017.08.017. Epub 2017 Aug 24.
8
Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events.血液透析患者单核细胞来源的髓样抑制细胞的扩增可能导致心血管和脑血管事件。
Front Immunol. 2021 Jan 29;11:577253. doi: 10.3389/fimmu.2020.577253. eCollection 2020.
9
Correlation between tumor markers and type 2 diabetes mellitus complications and their related influencing factors.肿瘤标志物与 2 型糖尿病并发症的相关性及其相关影响因素。
Ann Palliat Med. 2022 Jan;11(1):58-67. doi: 10.21037/apm-21-3429.
10
Myeloid-derived suppressor cells in gastroenteropancreatic neuroendocrine neoplasms.胃肠道胰腺神经内分泌肿瘤中的髓源性抑制细胞。
Endocrine. 2021 Jan;71(1):242-252. doi: 10.1007/s12020-020-02467-2. Epub 2020 Oct 3.

引用本文的文献

1
Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy.甘油三酯-葡萄糖指数与接受免疫治疗和靶向治疗的晚期肝细胞癌患者长期预后的关联
World J Gastroenterol. 2025 Aug 14;31(30):109863. doi: 10.3748/wjg.v31.i30.109863.
2
Role of Myeloid-Derived Suppressor Cells (MDSCs), Specifically Monocyte-Derived MDSCs, in Type 2 Diabetes-Related Diabetic Retinopathy.髓源性抑制细胞(MDSCs),特别是单核细胞衍生的MDSCs在2型糖尿病相关糖尿病视网膜病变中的作用。
Diabetes Metab Syndr Obes. 2025 Jul 6;18:2213-2220. doi: 10.2147/DMSO.S527411. eCollection 2025.
3

本文引用的文献

1
Diagnostic efficacy of cystatin-c in association with different ACE genes predicting renal insufficiency in T2DM.胱抑素 C 联合不同 ACE 基因预测 2 型糖尿病患者肾功能不全的诊断效能。
Sci Rep. 2023 Mar 31;13(1):5288. doi: 10.1038/s41598-023-32012-w.
2
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.髓系来源的抑制细胞:抗肿瘤免疫治疗的一个新靶点。
Mol Cancer. 2022 Sep 26;21(1):184. doi: 10.1186/s12943-022-01657-y.
3
Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin.
Cerebrospinal Fluid Leakage Combined with Blood Biomarkers Predicts Poor Wound Healing After Posterior Lumbar Spinal Fusion: A Machine Learning Analysis.
脑脊液漏合并血液生物标志物可预测腰椎后路融合术后伤口愈合不良:一项机器学习分析
Int J Gen Med. 2024 Nov 25;17:5479-5491. doi: 10.2147/IJGM.S487967. eCollection 2024.
4
Dual roles of myeloid-derived suppressor cells in various diseases: a review.髓系来源抑制性细胞在多种疾病中的双重作用:综述。
Arch Pharm Res. 2024 Jul;47(7):597-616. doi: 10.1007/s12272-024-01504-2. Epub 2024 Jul 15.
血液系统恶性肿瘤中的髓源性抑制细胞:硬币的两面。
Exp Hematol Oncol. 2022 Jul 19;11(1):43. doi: 10.1186/s40164-022-00296-9.
4
An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for mutation-driven intestinal tumorigenesis.先天 IL-25-ILC2-MDSC 轴为驱动突变的肠道肿瘤发生创造了有利于癌症的微环境。
Sci Immunol. 2022 Jun 3;7(72):eabn0175. doi: 10.1126/sciimmunol.abn0175.
5
Emerging Roles of Myeloid-Derived Suppressor Cells in Diabetes.髓源性抑制细胞在糖尿病中的新作用
Front Pharmacol. 2021 Dec 16;12:798320. doi: 10.3389/fphar.2021.798320. eCollection 2021.
6
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy.肿瘤免疫治疗中髓源性抑制细胞的概况
Biomark Res. 2021 Oct 24;9(1):77. doi: 10.1186/s40364-021-00333-5.
7
mTOR inhibitor INK128 promotes wound healing by regulating MDSCs.mTOR 抑制剂 INK128 通过调节 MDSCs 促进伤口愈合。
Stem Cell Res Ther. 2021 Mar 10;12(1):170. doi: 10.1186/s13287-021-02206-y.
8
Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia.循环单核细胞髓系来源的抑制细胞升高与急性髓系白血病不良预后相关。
J Immunol Res. 2020 Dec 21;2020:7363084. doi: 10.1155/2020/7363084. eCollection 2020.
9
Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.1 型糖尿病中的髓系来源的抑制性细胞是一个扩增的群体,表现出不同的 T 细胞抑制机制。
PLoS One. 2020 Nov 18;15(11):e0242092. doi: 10.1371/journal.pone.0242092. eCollection 2020.
10
Dendritic Cells and Myeloid Derived Suppressor Cells Fully Responsive to Stimulation via Toll-Like Receptor 4 Are Rapidly Induced from Bone-Marrow Cells by Granulocyte-Macrophage Colony-Stimulating Factor.通过Toll样受体4对刺激完全有反应的树突状细胞和髓源性抑制细胞可由粒细胞巨噬细胞集落刺激因子从骨髓细胞中快速诱导产生。
Vaccines (Basel). 2020 Sep 12;8(3):522. doi: 10.3390/vaccines8030522.